FR2390964A1 - Associations medicamenteuses comprenant de la prostacycline ou de la dihydroprostacycline - Google Patents

Associations medicamenteuses comprenant de la prostacycline ou de la dihydroprostacycline

Info

Publication number
FR2390964A1
FR2390964A1 FR7814729A FR7814729A FR2390964A1 FR 2390964 A1 FR2390964 A1 FR 2390964A1 FR 7814729 A FR7814729 A FR 7814729A FR 7814729 A FR7814729 A FR 7814729A FR 2390964 A1 FR2390964 A1 FR 2390964A1
Authority
FR
France
Prior art keywords
blood
pharmaceutical composition
dihydroprostacycline
prostacycline
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814729A
Other languages
English (en)
French (fr)
Other versions
FR2390964B1 (enrdf_load_stackoverflow
Inventor
Pedro Cuatrecasas
Salvador Moncada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2390964A1 publication Critical patent/FR2390964A1/fr
Application granted granted Critical
Publication of FR2390964B1 publication Critical patent/FR2390964B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7814729A 1977-05-20 1978-05-18 Associations medicamenteuses comprenant de la prostacycline ou de la dihydroprostacycline Granted FR2390964A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79900777A 1977-05-20 1977-05-20
GB3526177 1977-08-23

Publications (2)

Publication Number Publication Date
FR2390964A1 true FR2390964A1 (fr) 1978-12-15
FR2390964B1 FR2390964B1 (enrdf_load_stackoverflow) 1980-07-11

Family

ID=26262642

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814729A Granted FR2390964A1 (fr) 1977-05-20 1978-05-18 Associations medicamenteuses comprenant de la prostacycline ou de la dihydroprostacycline

Country Status (8)

Country Link
JP (1) JPS542335A (enrdf_load_stackoverflow)
CH (1) CH643458A5 (enrdf_load_stackoverflow)
DE (1) DE2821737A1 (enrdf_load_stackoverflow)
FR (1) FR2390964A1 (enrdf_load_stackoverflow)
HU (1) HU180548B (enrdf_load_stackoverflow)
IT (1) IT1105506B (enrdf_load_stackoverflow)
NL (1) NL7805402A (enrdf_load_stackoverflow)
SE (1) SE443716B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005768A1 (en) * 1978-05-17 1979-12-12 The Wellcome Foundation Limited Pharmaceutical formulations containing prostaglandin compounds and method for their preparation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3526362A1 (de) * 1985-07-19 1987-01-22 Schering Ag Prostacycline, ihre analoga oder prostaglandine und thromboxanantagonisten zur behandlung von thrombotischen und thromboembolischen krankheitsbildern
DE3874440T2 (de) * 1987-07-14 1993-01-28 Sankyo Co Zusammensetzung zur herstellung von antithrombotischen medizinischen erzeugnissen.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235678A1 (en) * 1973-07-02 1975-01-31 Merck & Co Inc Topical antipsoriasis agents - contg. prostaglandin E1 or E2

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235678A1 (en) * 1973-07-02 1975-01-31 Merck & Co Inc Topical antipsoriasis agents - contg. prostaglandin E1 or E2

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005768A1 (en) * 1978-05-17 1979-12-12 The Wellcome Foundation Limited Pharmaceutical formulations containing prostaglandin compounds and method for their preparation
FR2425856A1 (fr) * 1978-05-17 1979-12-14 Wellcome Found Medicament a base de prostaglandines

Also Published As

Publication number Publication date
NL7805402A (nl) 1978-11-22
FR2390964B1 (enrdf_load_stackoverflow) 1980-07-11
IT1105506B (it) 1985-11-04
IT7849485A0 (it) 1978-05-22
SE7805707L (sv) 1978-11-21
SE443716B (sv) 1986-03-10
DE2821737A1 (de) 1978-11-30
JPS542335A (en) 1979-01-09
DE2821737C2 (enrdf_load_stackoverflow) 1988-05-19
HU180548B (en) 1983-03-28
CH643458A5 (en) 1984-06-15

Similar Documents

Publication Publication Date Title
SE8402550D0 (sv) N-substituerade deriavat av moranolin
SE8001736L (sv) Indolerivat med terapeutisk verkan jemte sett for deras framstellning
NL970045I1 (nl) Desulfatohirudinen, werkwijze voor hun bereiding en farmaceutische middelen.
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
ES530046A0 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
SE8000435L (sv) N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning
ATA21888A (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
JPS57122085A (en) Circulatory disease extirpenter and use
MX157054A (es) Procedimiento para preparar derivados de disenzoxazepina
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
FR2390964A1 (fr) Associations medicamenteuses comprenant de la prostacycline ou de la dihydroprostacycline
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
IE810276L (en) Phenylpiperazine derivatives of oxadiazoles
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
SE409410B (sv) Kirurgisk kompressions- och vridningsanordning for behandling av skador pa och sjukdomar hos ben och leder
IT7824796A0 (it) Procedimento per il trattamento del la colibacillosi neonatale e relativo composto farmaceutico
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
FR2412313A1 (fr) Composition pharmaceutique a base de mono-saccharide et d'amino-acide administrable par voie orale a des etres humains
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
SU1113093A1 (ru) Способ лечени остеомиелита
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
ST Notification of lapse